2-14634592-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_145175.4(LRATD1):āc.613G>Cā(p.Glu205Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000705 in 1,502,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145175.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRATD1 | NM_145175.4 | c.613G>C | p.Glu205Gln | missense_variant | 2/2 | ENST00000295092.3 | NP_660158.2 | |
LRATD1 | NM_001369364.1 | c.613G>C | p.Glu205Gln | missense_variant | 3/3 | NP_001356293.1 | ||
LRATD1 | NR_144632.2 | n.870G>C | non_coding_transcript_exon_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRATD1 | ENST00000295092.3 | c.613G>C | p.Glu205Gln | missense_variant | 2/2 | 1 | NM_145175.4 | ENSP00000295092 | P1 | |
LRATD1 | ENST00000331243.4 | c.613G>C | p.Glu205Gln | missense_variant | 3/3 | 3 | ENSP00000330681 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000376 AC: 5AN: 133038Hom.: 0 AF XY: 0.0000285 AC XY: 2AN XY: 70112
GnomAD4 exome AF: 0.0000718 AC: 97AN: 1350702Hom.: 0 Cov.: 31 AF XY: 0.0000652 AC XY: 43AN XY: 659912
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2023 | The c.613G>C (p.E205Q) alteration is located in exon 2 (coding exon 1) of the FAM84A gene. This alteration results from a G to C substitution at nucleotide position 613, causing the glutamic acid (E) at amino acid position 205 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at